High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia
Official title: Gas Exchange, Clinical Outcomes, and Tolerability of High-Flow Nasal Cannula Versus Non-Invasive Ventilation in COPD Patients With Mild-to-Moderate Hypercapnic Respiratory Failure
Run by Mansoura University · NCT07854210 · Data updated 2026-11-12
This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Mansoura University Academic / other |
| Locations | 1 site (Al Mansurah, Dakahlia Governorate) |
| Status | Recruiting |
| Started | November 3, 2025 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT07854210 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with COPD hospitalized for mild-to-moderate hypercapnic respiratory failure, able to cooperate with the assigned therapy.
✕Probably not a fit
Patients with severe acidosis, instability, facial trauma, nasal deformities, urgent need for invasive ventilation, or non-cooperation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares two noninvasive respiratory support methods in adults hospitalized for COPD with mild-to-moderate hypercapnic respiratory failure. Patients are randomized or otherwise allocated to receive either high-flow nasal cannula or noninvasive ventilation to monitor gas exchange trends, clinical outcomes, and tolerability. The trial aims to determine which approach provides better physiological improvement and patient experience. It excludes patients with severe acidosis, instability, or conditions that could confound outcomes, ensuring a focus on tolerability and efficacy in this specific COPD subset. Conducted at the Faculty of Medicine, Mansoura University, under lead sponsor Mohammed Shehta, the study evaluates practical applicability of HFNC in this patient population.
Why it matters
Potential benefit: If successful, patients with COPD and hypercapnic respiratory failure could have a more comfortable and potentially effective respiratory support option.
How similar studies have gone: Previous work in noninvasive support for COPD has shown benefits with NIV; this study explores HFNC in a similar clinical scenario and may provide comparative data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * COPD patients hospitalized with mild-to-moderate hypercapnic respiratory failure, defined as arterial pH \[range, e.g., 7.25-7.35\] and PaCO2 \[threshold, e.g., \>45 mmHg and less 60 mmHg\]. Exclusion Criteria: * patients with altered mental state, confused, severe agitation or not cooperative were excluded. Also, severe acidosis (pH \<7.25), hemodynamic instability, facial trauma or surgery, cases with severe nasal deformity, immediate indication for invasive ventilation, patient refusal, cases with respiratory rate more than 35 breaths per minute. Respiratory exhaustion, excess use of respiratory accessory muscles, Patients with breathing disorders during sleep as well as cases of upper airway obstruction and patients with history of chronic home ventilation prior admission were another items for exclusion
Where it's running
-
Faculty of Medicine, Mansoura University
Al Mansurah, Dakahlia Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Mohammed Shehta, associate professor-chest med.
- Email: dr_mshehta@mans.edu.eg
- Phone: 01004344106
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
Biologics for Type 2 Inflammation in Asthma and COPD in Real World
This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.
-
Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers
This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.
-
New breathing tests to diagnose airway disease in hospital and community settings
This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.
-
Tele-pulmonary rehab after COPD hospitalization
A tele-rehabilitation program is being tested to see if it helps people with COPD recover after being hospitalized for an acute exacerbation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.